Metal-organic framework and oxygen adsorption material using same

A zinc-based metal-organic framework with specific ligands and pore volume enhances oxygen adsorption and desorption control, addressing MOF limitations in air adsorption and enabling efficient oxygen management devices.

JP7590200B2Active Publication Date: 2024-11-26TOYOTA JIDOSHA KK +1
View PDF 1 Cites 0 Cited by

Patent Information

Application Number
JP2021016383
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2021-02-04
Publication Date
2024-11-26
Estimated Expiration
2041-02-04

AI Technical Summary

Technical Problem

Existing metal-organic frameworks (MOFs) lack sufficient oxygen adsorption ability in air and have difficulty in controlling oxygen adsorption and desorption processes.

Method used

A metal-organic structure comprising a zinc ion, a first ligand with an anthracene structure and no charge, and a second ligand with negative charge and multiple coordination groups, with a pore volume of 2.0 vol% or more after desolvation, allowing for efficient oxygen adsorption and desorption through chemical bonding and photosensitization.

Benefits of technology

The MOF efficiently adsorbs oxygen in air and allows for easy control of adsorption and desorption using external stimuli like light and heat, enabling applications in oxygen enrichment, storage, and generation devices.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007590200000006
    Figure 0007590200000006
  • Figure 0007590200000007
    Figure 0007590200000007
  • Figure 0007590200000008
    Figure 0007590200000008
Patent Text Reader

Abstract

To provide a metal organic structure capable of efficiently adsorbing oxygen in the air and easily controlling adsorption-desorption of the oxygen.SOLUTION: A metal organic structure includes a metal ion, a first ligand, and a second ligand. The metal organic structure is such that a pore volume after solvent-removing treatment is 2.0 vol% or more, the metal ion is a zinc ion, the first ligand comprises an organic compound having no electric charge and having an anthracene structure, and the second ligand comprises an organic compound ion having two or more ligand groups and having a negative electric charge.SELECTED DRAWING: Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present disclosure relates to a metal-organic framework. The present disclosure also relates to an oxygen adsorbing material using the metal-organic framework, and an oxygen enrichment device, an oxygen storage device, an oxygen removal device, and an oxygen generation device using the oxygen adsorbing material. [Background technology]

[0002] Metal organic frameworks (MOFs), which are porous compounds, are also known as porous coordination polymers (PCPs). MOFs have a high surface area coordination network structure formed by the interaction of metals with organic ligands.

[0003] In recent years, various research and development efforts have been conducted on such metal-organic frameworks.

[0004] For example, Patent Document 1 discloses a metal organic framework having oxygen adsorption ability and consisting of a metal ion and a multidentate ligand.

[0005] Furthermore, Non-Patent Document 1 discloses a metal organic framework that adsorbs and releases oxygen in a liquid. [Prior art documents] [Patent documents]

[0006] [Patent Document 1] US Patent Application Publication No. 2005 / 0105250 [Non-patent literature]

[0007] [Non-Patent Document 1] Ryotaro Matsuda et al., “Trapping and Releasing of Oxygen in Liquid by Metal-Organic Framework with Light and Heat”, “Small”, 2020, 2004351. Summary of the Invention [Problem to be solved by the invention]

[0008] However, the MOF of Patent Document 1 has a problem that oxygen adsorption capacity is insufficient because oxygen is physically adsorbed, and the adsorption and desorption of oxygen cannot be easily controlled. Note that physical adsorption refers to an adsorption state in which the adsorption is weakly bound by van der Waals forces or the like.

[0009] Furthermore, the MOF in Non-Patent Document 1 adsorbs oxygen in a solvent, and has the problem of being unable to adequately adsorb oxygen in the air.

[0010] Therefore, the present disclosure has been made in consideration of the above circumstances, and aims to provide a MOF that has an improved ability to adsorb oxygen in the air and can easily control the adsorption and desorption of oxygen. [Means for solving the problem]

[0011] As a result of intensive research, the inventors of the present disclosure have found that the above problems can be solved by the following means.

[0012] <Aspect 1> A metal organic framework comprising a metal ion, a first ligand, and a second ligand, The pore volume after the solvent removal treatment is 2.0 vol% or more, the metal ion is a zinc ion, The first ligand is an organic compound that has no charge and has an anthracene structure, The second ligand is an organic compound ion having two or more coordinating groups and having a negative charge. Metal-organic structures. <Aspect 2> The metal organic framework according to embodiment 1, wherein the first ligand comprises a pyridyl group as a functional group that forms a coordinate bond with the metal ion. <Aspect 3> 3. The metal organic framework of embodiment 2, wherein the first ligand comprises 9,10-di(4-pyridyl)anthracene or 9-(4-pyridyl)anthracene. <Aspect 4> The metal organic framework according to any one of aspects 1 to 3, wherein the second ligand comprises a polyvalent carboxylate ion. <Aspect 5> 5. The metal organic framework of embodiment 4, wherein the second ligand comprises 2,6-naphthalenedicarboxylate, 4,4′-biphenyldicarboxylate, or 4,4′,4”,4′″-benzene-1,2,4,5-tetrayltetrabenzoate. <Aspect 6> An oxygen adsorbing material comprising the metal organic framework according to any one of aspects 1 to 5. Aspect 7 An oxygen enrichment device, an oxygen storage device, an oxygen scavenger, or an oxygen generation device comprising the oxygen adsorbing material of embodiment 6. Effect of the Invention

[0013] The MOF of the present disclosure can efficiently adsorb oxygen from the air, and the adsorption and desorption of oxygen can be easily controlled. [Brief description of the drawings]

[0014] [Figure 1] FIG. 1 shows the structural formulas of the raw materials used in Example 3 and the crystal structure of the product MOF of Example 3. [Diagram 2] FIG. 2 is a diagram showing the process of generating singlet oxygen by the photosensitization method. [Diagram 3] FIG. 3 shows (a) the molecular structure of 9,10-di(4-pyridyl)anthracene, (b) its molecular structure when an EPO bond is formed, and (c and d) their simplified structures. [Figure 4] FIG. 4 shows X-ray diffraction patterns of the MOFs of Examples 1 to 3 and Comparative Example 2. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0015] Hereinafter, embodiments of the present disclosure will be described in detail. Note that the present disclosure is not limited to the following embodiments, and various modifications can be made within the scope of the present disclosure.

[0016] 《Metal-organic framework (MOF)》 The MOF of the present disclosure is A metal organic framework comprising a metal ion, a first ligand, and a second ligand, The pore volume after the solvent removal treatment is 2.0 vol% or more, the metal ion is a zinc ion; The first ligand is an organic compound that has no charge and has an anthracene structure, The second ligand is an organic compound ion having two or more coordinating groups and having a negative charge. metal organic framework It is.

[0017] FIG. 1 shows the structural formulas of the raw materials used in Example 3 of the present disclosure, and the crystal structure of the product MOF of Example 3.

[0018] As shown in FIG. 1, the MOF of Example 3 is a metal organic framework including a metal ion, a first ligand, and a second ligand. More specifically, in the MOF of Example 3, the metal ion is a zinc ion, the first ligand is 9,10-di(4-pyridyl)anthracene, and the second ligand is a 4,4',4'',4''''-benzene-1,2,4,5-tetrayltetrabenzoate ion. In addition, the pore volume of the MOF of Example 3 after the solvent removal treatment is 37.0 vol%.

[0019] In the present disclosure, the pore volume of MOF after the desolvation treatment is calculated by first analyzing the crystal structure of the MOF after the desolvation treatment to determine the atomic coordinates in the unit lattice, then calculating the volume occupied by the atoms in the unit lattice using the atomic radius of each element, and calculating the proportion of the remaining space as the total pore volume.

[0020] The reason why the MOF of the present disclosure can exhibit the effects of the present disclosure is presumed to be as follows, without being limited to theory.

[0021] Since the first ligand of the MOF of the present disclosure is an organic compound having an anthracene structure, oxygen can be adsorbed and desorbed by utilizing the reaction shown in the following scheme.

[0022] [ka]

[0023] More specifically, organic compounds having an anthracene structure can trap singlet oxygen ( 1 O 2 ) to form endoperoxide (epo) bonds. By utilizing this reaction, chemical bonds are formed between the pore surface of MOFs containing anthracene structures and oxygen molecules, which is believed to enable oxygen capture more powerfully than physical adsorption. In addition, this reaction is reversible, and oxygen can be released by heating, so it is believed that oxygen absorption and desorption can be easily controlled.

[0024] However, the ground state triplet oxygen ( 3 O 2 )of 1 O 2 Since direct excitation to is a forbidden transition, it cannot be generated by heat or light alone. Therefore, the photosensitization method shown in Figure 2 is used. The photosensitizer is excited by light, and when the excited photosensitizer returns to the ground state, 3 O 2 By exchanging energy between the two, oxygen molecules are converted from the ground state to 1 O2 The anthracene structure is known to have photosensitizing properties, so when light is irradiated, the anthracene structure is first excited to 3 O 2 There is an exchange of energy between 1 O 2 It is thought that this will be generated. 1 O 2 By reacting with the anthracene structure, EPO bonds can be formed. In other words, it is thought that oxygen can be captured even under low pressure.

[0025] However, according to the intensive research of the present inventors, it was found that not all MOFs can exhibit the above-mentioned photosensitizing effect and capture oxygen simply by having an anthracene structure. In addition, for example, the MOF disclosed in Non-Patent Document 1 can capture oxygen in a solution, but when an attempt was made to remove the solvent from this MOF and capture oxygen in the air, it was found that only a small amount of oxygen could be captured.

[0026] Therefore, the inventors of the present disclosure conducted further intensive research and focused on the presence or absence of a charge in the organic compound having an anthracene structure, and the pore volume of the MOF after the solvent removal treatment.

[0027] More specifically, the inventors of the present disclosure have found through intensive research that when an organic compound having an anthracene structure has a charge, particularly when a negative charge is present at a position close to the anthracene structure, conjugation occurs between the benzene ring of anthracene and the negative charge, which weakens the effect of the anthracene structure as a photosensitizer. Based on this finding, the inventors of the present disclosure have come to specify that the organic compound having an anthracene structure as a first ligand does not have a charge.

[0028] Further, through further intensive research by the present inventors, it has been found that the size of the pore volume of the MOF is important for adsorbing oxygen in the air. As an example, 9,10-di(4-pyridyl)anthracene shown in FIG. 3 will be used for explanation. Note that 9,10-di(4-pyridyl)anthracene can be used as the first ligand of the MOF of the present disclosure.

[0029] FIG. 3(a) is a diagram showing the molecular structure of 9,10-di(4-pyridyl)anthracene, and FIG. 3(c) is a diagram showing a simplified structure thereof. FIG. 3(b) is a diagram showing the molecular structure when 9,10-di(4-pyridyl)anthracene reacts with oxygen to form an EPO bond, and FIG. 3(d) is a diagram showing a simplified structure thereof. As can be seen from FIG. 3(b) and (d), when 9,10-di(4-pyridyl)anthracene reacts with oxygen to form an EPO bond, the positional relationship of the substituents coordinated with the metal ion (indicated by arrows in FIG. 3(c) and 3(d)) hardly changes, whereas the anthracene structure is slightly bent, and a convexity is formed at the position where the oxygen molecule is bonded. In other words, it is considered that a certain amount of pore volume is necessary to allow the deformation accompanying the formation of such an EPO bond.

[0030] It was also found that the pore volume of the MOF changes before and after the desolvation treatment. That is, even if the pore volume of the MOF before the desolvation treatment is large enough to adsorb oxygen, it is possible that the pore volume becomes smaller after the desolvation treatment, and there is no space to adsorb oxygen. For example, the MOF of Non-Patent Document 1 (MOF having the same structure as Comparative Example 2 described later) can adsorb oxygen in liquid, but its ability to adsorb oxygen in air decreases after desolvation. This is because the MOF of Non-Patent Document 1, when desolvated, has a different crystal structure, changing from double interpenetration to triple interpenetration in the solvent, and as a result, the pore volume becomes smaller and there is no space to adsorb oxygen. From this knowledge, the present inventors of the present disclosure have found that by making the pore volume of the MOF after the solvent treatment 2.0 vol% or more, it is possible to secure a space to adsorb oxygen in the air.

[0031] In addition, MOFs are usually synthesized in a solvent. This solvent can be removed by post-synthesis treatment, but in some cases, some of the solvent molecules may be incorporated into the skeleton of the synthesized MOF, i.e., may form coordinate bonds with the skeleton of the MOF. Therefore, in this disclosure, "removal of solvent" means that the solvent that is not coordinate-bonded with the skeleton of the MOF after synthesis is completely removed by post-treatment. A more specific method for removing the solvent will be described in the "MOF manufacturing method" described later.

[0032] <Metal ions> The metal ions used in the MOFs of the present disclosure are zinc ions (Zn 2+ ).

[0033] In the MOFs of the present disclosure, the zinc ions may be penta-coordinated, for example forming pyramidal coordination bonds.

[0034] The zinc ion source is not particularly limited as long as it contains zinc atoms, and for example, at least one selected from the group consisting of zinc chloride, zinc nitrate, and zinc sulfate may be used. In addition, hydrates of the above-mentioned zinc ion source compounds may also be used as the zinc ion source. As such a hydrate of the zinc ion source compound, for example, zinc nitrate hexahydrate (Zn(NO 3 ) 2 6H 2 O), but is not limited to these.

[0035] <First Ligand> The first ligand used in the MOF of the present disclosure is an organic compound that has no charge and has an anthracene structure.

[0036] In the present disclosure, the first ligand may include a functional group that forms a coordinate bond with zinc ion. For example, the first ligand may include a pyridyl group as a functional group that forms a coordinate bond with metal ion. In addition, the pyridyl group as this functional group may have a substituent such as a methyl group, an ethyl group, or a halogen atom, as long as it does not impair the effect of the present disclosure.

[0037] More specifically, the first ligand according to the present disclosure may include, for example, 9,10-di(4-pyridyl)anthracene (also abbreviated as "dpa") or 9-(4-pyridyl)anthracene (also abbreviated as "pa") represented by the following chemical formula: In the MOF of the present disclosure, it is believed that the nitrogen atom of the pyridyl group of dpa and pa mainly forms a coordinate bond with the zinc ion as the metal ion.

[0038] [ka]

[0039] In the present disclosure, the first ligand to be used may be a commercially available one or a synthesized one.

[0040] In the MOF of the present disclosure, the proportion of the first ligand is not particularly limited, and may be, for example, more than 0 mol%, 5 mol% or more, 10 mol% or more, 15 mol% or more, 20 mol% or more, 25 mol% or more, 30 mol% or more, 35 mol% or more, 40 mol% or more, 45 mol% or more, 50 mol% or more, 55 mol% or more, 60 mol% or more, or 65 mol% or more, or may be 80 mol% or less, 75 mol% or less, or 70 mol% or less, relative to the total of the first ligand and the second ligand.

[0041] <Second Ligand> The second ligand used in the MOF of the present disclosure is an organic compound ion having two or more coordinating groups and having a negative charge.

[0042] In the second ligand, the two or more coordinating groups are for forming a coordinate bond with a zinc ion, and more specifically, the number of the coordinating groups may be two or four. Such a coordinating group may be, for example, a carboxy group.

[0043] The reason why the second ligand is an organic compound ion having a negative charge is that the first ligand does not have a charge, and therefore the positive charge of the metal ion (zinc ion) is compensated for.

[0044] In the present disclosure, the coordinating group may be a carboxy group, and therefore the second ligand may be a polycarboxylate ion, which refers to an ionized carboxylic acid having two or more carboxy groups (-COOH).

[0045] More specifically, the second ligand according to the present disclosure is, for example, terephthalic acid represented by the following chemical formula ("H 2 BDC), 2,6-naphthalenedicarboxylic acid (H 2 NDC), 4,4'-biphenyldicarboxylic acid (H 2 BPDC), or 4,4',4'',4''-benzene-1,2,4,5-tetrayltetrabenzoic acid (H 4The cations may include ions of

[0046] [ka]

[0047] Of these, the second ligand according to the present disclosure preferably includes a 2,6-naphthalenedicarboxylate ion, a 4,4'-biphenyldicarboxylate ion, or a 4,4',4'',4''-benzene-1,2,4,5-tetrayltetrabenzoate ion.

[0048] In the present disclosure, the second ligand may be a commercially available one or may be synthesized.

[0049] In the MOF of the present disclosure, the proportion of the second ligand is not particularly limited, and may be, for example, more than 0 mol%, 5 mol% or more, 10 mol% or more, 15 mol% or more, 20 mol% or more, 25 mol% or more, 30 mol% or more, 35 mol% or more, 40 mol% or more, 45 mol% or more, 50 mol% or more, 55 mol% or more, 60 mol% or more, or 65 mol% or more, or may be 80 mol% or less, 75 mol% or less, or 70 mol% or less, relative to the total of the first ligand and the second ligand.

[0050] <Pore volume> The MOF of the present disclosure has a pore volume of 2.0 vol% or more after the solvent removal treatment. More specifically, the pore volume of the MOF of the present disclosure after the solvent removal treatment is 2.0 vol% or more, 2.5 vol% or more, 3.0 vol% or more, 3.5 vol% or more, 4.0 vol% or more, 4.5 vol% or more, 4.8 vol% or more, 5.0 vol% or more, 5.5 vol% or more, 6.0 vol% or more, 6.5 vol% or more, 7.0 vol% or more, 7.5 vol% or more, 8.0 vol% or more, 8.2 vol% or more, 8.5 vol% or more, 9.0 vol% or more, 10.0 vol% or more, 11.0 vol% or more, 12.0 vol% or more, 13.0 vol% or more, 14.0 vol% or more, 15.0 vol% or more, 16.0 vol% or more, 17.0 vol% or more, 18.0 vol% or more, 19.0 vol% or more, 20.0 vol% or more, 21.0 vol% or more, 22.0 vol% or more, 23.0 vol% or more, 24.0 vol% or more, 25.0 vol% or more, 26.0 vol% or more, 27.0 vol% or more, 28.0 vol% or more, 29.0 vol% or more, 30.0 vol% or more, 31.0 vol% or more, 32.0 vol% or more, 33.0 vol% or more, 34.0 vol% or more, 35.0 vol% or more, 36.0 vol% or more, 12.0 vol% or more, 13.0 vol% or more, 14.0 vol% or more, 15.0 vol% or more, 16.0 vol% or more, 17.0 vol% or more, 18.0 vol% or more, 19.0 vol% or more, 20.0 vol% or more, 25.0 vol% or more, 30.0 vol% or more, 35.0 vol% or more, or 37.0 vol% or more, and may be 80.0 vol% or less, 70.0 vol% or less, 60.0 vol% or less, or 50.0 vol% or less.

[0051] <<MOF manufacturing method>> The MOFs of the present disclosure can be produced, for example, by mixing raw materials at room temperature, or using hydrothermal or solvothermal synthesis methods.

[0052] When MOFs are produced by heating, more specifically, a raw material solution containing a zinc ion source as a metal ion source, a first ligand source, a second ligand source, and a solvent is heated to react, and then the solvent is removed in a post-treatment to produce the MOF of the present disclosure.

[0053] Here, the concentration of zinc ions contained in the raw material solution is not particularly limited, and may be, for example, 5 mmol / L or more, 10 mmol / L or more, 15 mmol / L or more, 20 mmol / L or more, 25 mmol / L or more, 30 mmol / L or more, 35 mmol / L or more, 40 mmol / L or more, 45 mmol / L or more, or 50 mmol / L or more, and may be 200 mmol / L or less, 100 mmol / L or less, or 50 mmol / L or less, relative to the solvent.

[0054] In addition, the respective concentrations of the first ligand and the second ligand contained in the raw material solution are not particularly limited, and may be, for example, independently, 2.0 mmol / L or more, 2.5 mmol / L or more, 3.0 mmol / L or more, 3.5 mmol / L or more, 4.0 mmol / L or more, 4.5 mmol / L or more, 5.0 mmol / L or more, 5.5 mmol / L or more, 6.0 mmol / L or more, 6.5 mmol / L or more, 7.0 mmol / L or more, 7.5 mmol / L or more, 8.0 mmol / L or more, 8.5 mmol / L or more, 9.0 mmol / L or more, 9.5 mmol / L or more, 10.0 mmol / L or more, 15.0 mmol / L or more, or 20.0 mmol / L or more, and may be 200 mmol / L or less, 100 mmol / L or less, or 50 mmol / L or less, relative to the solvent.

[0055] Examples of solvents include, but are not limited to, N,N-dimethylformamide (DMF), N,N-diethylformamide (DEF), formic acid, acetic acid, methanol, ethanol, water, and mixtures thereof.

[0056] During heating, the raw material solution may be placed in an arbitrary sealed container, or may be heated while refluxing the raw material solution.

[0057] The heating temperature is not particularly limited, and may be, for example, 80°C or more, 100°C or more, or 120°C or more from the viewpoint of increasing the reactivity, and may be 200°C or less, or 150°C or less from the viewpoint of preventing steam leakage during the reaction.

[0058] The heating time is not particularly limited and can be appropriately adjusted according to the heating temperature. For example, from the viewpoint of completing the reaction, the heating time may be 6 hours or more, 10 hours or more, 12 hours or more, 18 hours or more, 24 hours or more, 30 hours or more, 36 hours or more, 42 hours or more, 48 hours or more, 54 hours or more, or 60 hours or more, and may be 96 hours or less, 84 hours or less, 72 hours or less, 60 hours or less, 48 ​​hours or less, 24 hours or less, 12 hours or less, or 10 hours or less.

[0059] The post-treatment essentially includes a desolvation operation. Here, the desolvation operation may include, for example, drying the product. Here, the drying may be performed under normal pressure or under reduced pressure, but it is preferable to perform it under reduced pressure from the viewpoint of improving efficiency. The temperature during drying may be, for example, 100°C or higher, 120°C or higher, 130°C or higher, 140°C or higher, or 150°C or higher, and may be 180°C or lower, 170°C or higher, or 160°C or lower. The drying time during drying may be, for example, 1 hour or more, 2 hours or more, 6 hours or more, 10 hours or more, or 12 hours or more, and may be 24 hours or less, or 16 hours or less.

[0060] As a post-treatment, an operation such as filtration may be optionally carried out. In this case, the filtration may be carried out before the solvent removal operation.

[0061] Oxygen Adsorption Material The present disclosure also provides an oxygen adsorbing material comprising a MOF of the present disclosure.

[0062] The oxygen adsorbing material of the present disclosure can efficiently adsorb oxygen in the air, and can easily desorb the adsorbed oxygen.

[0063] The oxygen adsorbing material of the present disclosure is capable of adsorbing oxygen in the air upon irradiation with light.

[0064] Here, the light source for light irradiation is not particularly limited, and examples thereof include a halogen lamp, a metal halide lamp, a high-power metal halide lamp (containing indium, etc.), a low-pressure mercury lamp, a high-pressure mercury lamp, an ultra-high-pressure mercury lamp, a xenon lamp, a xenon excimer lamp, a xenon flash lamp, and a light-emitting diode (hereinafter referred to as an LED).

[0065] Furthermore, the atmosphere for light irradiation is not particularly limited as long as it contains gaseous oxygen, which is the object of adsorption, and may be, for example, an oxygen atmosphere at atmospheric pressure (approximately 100 kPa), or an air atmosphere in which nitrogen, water vapor, etc. coexist.

[0066] The time of light irradiation is not particularly limited and may be, for example, 1 hour or more, 5 hours or more, 8 hours or more, 10 hours or more, 20 hours or more, 24 hours or more, 30 hours or more, 36 hours or more, or 40 hours or more, or may be 200 hours or less, 100 hours or less, or 50 hours or less. The time of light irradiation may be shorter for MOFs with larger pore volumes after the solvent removal treatment.

[0067] The temperature during light irradiation is not particularly limited, and may be, for example, a temperature higher than the boiling point of oxygen (approximately -182.96°C); more specifically, for example, the temperature may be -180°C or higher, -150°C or higher, -100°C or higher, -78°C or higher, -58°C or higher, -38°C or higher, -18°C or higher, 0°C or higher, 2°C or higher, 10°C or higher, 20°C or higher, 25°C or higher, 30°C or higher, 35°C or higher, or 40°C or higher, or may be 50°C or lower, 40°C or lower, 30°C or lower, or 25°C or lower.

[0068] The oxygen adsorbing material of the present disclosure is capable of desorbing the adsorbed oxygen by heating.

[0069] Here, the heating temperature is not particularly limited and may be, for example, 60°C or higher, 70°C or higher, 80°C or higher, 90°C or higher, or 100°C or higher, and may be 200°C or lower, or 150°C or lower.

[0070] The heating time is not particularly limited, and may be, for example, 1 hour or more, 2 hours or more, 3 hours or more, or 4 hours or more, and may be 48 hours or less, 24 hours or less, or 12 hours or less.

[0071] The oxygen adsorption amount of the oxygen adsorbing material of the present disclosure can be evaluated by the EPO content ratio. Here, the EPO content ratio of the oxygen adsorbing material of the present disclosure can be, for example, 1.00 mol% or more, 1.41 mol% or more, 5.66 mol% or more, 10.6 mol% or more, 11.2 mol% or more, 12.3 mol% or more, 16.1 mol% or more, 16.5 mol% or more, 20.5 mol% or more, 21.8 mol% or more, 22.0 mol% or more, 24.1 mol% or more, 30.0 mol% or more, 52.8 mol% or more, or 67.0 mol% or more.

[0072] The EPO conversion rate is the rate at which the anthracene skeleton of the oxygen adsorbing material reacts with oxygen to form EPO bonds. 1 It can be obtained from H-NMR spectrum. More specifically, first, the MOF after epo-conjugation is decomposed, and an internal standard is added to the solution. 1 Next, the H-NMR spectrum was measured. 1 The epo rate of the anthracene skeleton contained in the MOF is calculated from the integral ratio of the intensity of the H-NMR spectrum.

[0073] "Device" The present disclosure also provides an oxygen enrichment device, an oxygen storage device, an oxygen scavenger device, or an oxygen generator device comprising the oxygen adsorbing material of the present disclosure.

[0074] This is because the oxygen-adsorbing material of the present disclosure contains the MOF of the present disclosure, and thus the adsorption and desorption of oxygen can be controlled by external forces such as light and heat. EXAMPLES

[0075] The present disclosure will be described in more detail with reference to the following examples, but the scope of the present disclosure is not limited to the examples.

[0076] The following reagents were used to synthesize the MOFs of the examples and comparative examples: Zinc nitrate hexahydrate (Zn(NO 3 ) 2 6H 2 O): Fujifilm Wako Pure Chemical Corporation 9,10-Di(4-pyridyl)anthracene (dpa): Synthesized with reference to Non-Patent Document 2 9-(4-pyridyl)anthracene (pa): Synthesized with reference to Non-Patent Document 3 Terephthalic acid (H 2 BDC): Fujifilm Wako Pure Chemical Corporation 2,6-Naphthalenedicarboxylic acid (H 2 NDC): Fujifilm Wako Pure Chemical Corporation 1,2,4,5-Tetrakis(4-carboxyphenyl)benzene (H 4 TCPB): Sigma-Aldrich N,N-Dimethylformamide (DMF): Fujifilm Wako Pure Chemical Industries, Ltd. Ethanol (EtOH): Fujifilm Wako Pure Chemical Industries, Ltd. Formic acid (HCOOH): Fujifilm Wako Pure Chemical Industries, Ltd. -Non-Patent Document 2: W. Fudickar et al., “Synthesis of Pyridylanthracenes and Their Reversible Reaction with Singlet Oxygen to Endoperoxides” J. Org. Chem. (2017) 9258-9262. -Non-patent document 3: N. Miyaura et al., “Stereoselective synthesis of arylated (E)-alkenes by the reaction of alk-1-enylboranes with aryl halides in the presence of palladium catalyst” J. Chem. Soc., Chem. Commun. (1979) 866-867.

[0077] Example 1 As a metal ion source, 59.502 mg (0.2 mmol) of Zn(NO 3 )2·6H 2 O. 33.243 mg (0.1 mmol) of dpa as the first ligand source; As the second ligand source, 48.446 mg (0.2 mmol) of H 2 BPDC, and 10mL DMF as solvent The raw material solution using the above was placed in a 25 mL autoclave and heated at 100° C. for 72 hours.

[0078] The product was dried (heated under reduced pressure) at 140° C. to give the MOF of Example 1.

[0079] X-ray diffraction measurements were carried out on the MOF of Example 1. The results are shown in Figure 4. The measurement conditions were as follows: Measurement equipment: VariMax single crystal structure analysis equipment for extremely small crystals (Rigaku Corporation) ·X-ray used: Mo Kα ray (λ=0.71069Å) ·Measurement temperature: -180℃

[0080] Example 2 As a metal ion source, 29.749 mg (0.1 mmol) of Zn(NO 3 ) 2 6H 2 O. 25.531 mg (0.1 mmol) of pa as the first ligand source; As the second ligand source, 21.619 mg (0.1 mmol) of H 2 NDC, and As a solvent, 10 mL of DMF The mixture was placed in a 25 mL autoclave and heated at 100° C. for 48 hours.

[0081] The product was dried at 150° C. (heated under reduced pressure) to obtain the MOF of Example 2. X-ray diffraction measurement was performed on the obtained MOF of Example 2 in the same manner as for the MOF of Example 1. The results are shown in FIG.

[0082] Example 3 As a metal ion source, 2.78 mg (0.0095 mmol) of Zn(NO 3 ) 2 6H 2 O. 3.28 mg (0.01 mmol) of dpa as the first ligand source; As a second ligand source, 2.81 mg (0.005 mmol) of H 4 TCPB, and As a solvent, 1.4 mL of DMF, 0.6 mL of ethanol, and 20 μL of formic acid After placing in a 25mL autoclave, o C for 24 hours.

[0083] The product was dried at 150°C (heated under reduced pressure) to obtain the MOF of Example 3. X-ray diffraction measurement was performed on the obtained MOF of Example 3 in the same manner as for the MOF of Example 1. The results are shown in Figure 4. The crystal structure of the MOF of Example 3 is shown in Figure 1.

[0084] In addition, when the crystal structures (not shown) of the MOFs obtained in Examples 1 and 2 were compared with the crystal structure of the MOF obtained in Example 3, it was found that the crystal structures of the MOFs in Examples 1 to 3 had a common bonding pattern between the metal ions and the ligands (two pentacoordinate Zn atoms, four carboxyl groups in the xy directions, and two nitrogen atoms such as pyridine in the z-axis direction).

[0085] Comparative Example 1 As a metal ion source, 59.502 mg (0.2 mmol) of Zn(NO 3 ) 2 6H 2 O. 33.243 mg (0.1 mmol) of dpa as the first ligand source; As the second ligand source, 33.228 mg (0.2 mmol) of H 2 BDCs, and As a solvent, 10 mL of DMF After placing in a 25mL autoclave, o C for 72 hours.

[0086] When the product was dried at 140° C. (heated under reduced pressure), it decomposed and lost its crystallinity, i.e., the product of Comparative Example 1 was unstable.

[0087] In Comparative Example 1, the crystal structure of the product before the solvent was removed (that is, the product in a state in which the solvent was contained inside the pores of the MOF) was analyzed and its structural formula was identified. The results are shown in Table 1.

[0088] Comparative Example 2 As a metal ion source, 59.502 mg (0.2 mmol) of Zn(NO 3 ) 2 6H 2 O. As the first ligand, 33.243 mg (0.1 mmol) of dpa, As the second ligand, 43.238 mg (0.2 mmol) of H 2 NDC, and As a solvent, 10 mL of DMF After placing in a 25mL autoclave, o C for 72 hours.

[0089] The product was dried at 200° C. (heated under reduced pressure) to obtain the MOF of Comparative Example 2. X-ray diffraction measurement was performed on the obtained MOF of Comparative Example 2 in the same manner as for the MOF of Example 1. The results are shown in FIG.

[0090] <Measurement of Pore Volume> The crystal structures of the MOFs of Examples 1 to 3 and the MOF of Comparative Example 2 obtained above were analyzed using analysis software to determine the atomic coordinates in the unit lattice. The volume of the atoms in the unit lattice was then determined using the atomic radius of each element, and the remaining space was taken as the total pore volume. The pore volumes of each MOF obtained are shown in Table 1 below.

[0091] [Table 1]

[0092] <Oxygen adsorption experiment (EPO conversion)> The MOFs of Examples 1 to 3 and the MOF of Comparative Example 2 obtained above were irradiated with light in the presence of oxygen and subjected to an oxygen adsorption experiment. The experimental conditions were as follows: Light irradiation device: Optical Modulex SX-UI 501HQ (manufactured by Ushio Inc.) Light source: Ultra-high pressure mercury lamp USH-500SC (manufactured by Ushio Inc.) Atmosphere: 100kPa O 2 or in the air (details are shown in Table 2) Irradiation time: 1 to 40 hours (details shown in Table 2) Temperature: -78 to 25°C (see Table 2 for details)

[0093] As a result, the MOF of Comparative Example 2 showed only a small amount of oxygen adsorption. In contrast, the MOFs of Examples 1 to 3 showed clear oxygen adsorption. For this reason, the oxygen adsorption amount (epo conversion rate) was examined for the MOFs of Examples 1 to 3 as shown below.

[0094] The reason why the MOF of Comparative Example 2 showed only a small amount of oxygen adsorption is presumably because, as is clear from the results in Table 1, the pore volume was insufficient to allow for the deformation of the ligand associated with EPO conversion.

[0095] <Measurement of oxygen adsorption amount (EPO conversion rate)> The MOFs of Examples 1 to 3 were converted to epo as described above, decomposed, and an internal standard was added to the solution. 1 The H-NMR spectrum was measured. The epo ratio of the anthracene skeleton contained in the MOF was calculated from the integral ratio of the intensities, and the measurement was performed three times to obtain the average value. The decomposition and measurement conditions were as follows: Decomposition conditions: MOF was decomposed into 20 wt% deuterated hydrochloric acid (DCl)-dimethyl sulfoxide (DMSO-d 6 ) solution Internal standard: Tetramethylsilane was added as an internal standard. ·Measuring device: JNM-ECS400 (manufactured by JEOL Ltd.) ·Measurement temperature: 25 o C Number of times: 16

[0096] [Table 2]

[0097] As is clear from Table 2, the MOFs of Examples 1 to 3 adsorb oxygen (i.e., convert to EPO) even in an oxygen atmosphere at atmospheric pressure at temperatures higher than the boiling point of oxygen (-182.96°C), and it was confirmed that more than 10.0 mol% of the anthracene structure converts to EPO even at around room temperature, and that oxygen can be adsorbed even in the air (in the coexistence of nitrogen, water vapor, etc.) (for example, the MOF of Example 2).

[0098] These results demonstrate that the MOF disclosed herein can be used as an oxygen adsorption material.

[0099] Furthermore, as shown in Table 2, for the MOF of Example 3 that had adsorbed oxygen (EPO conversion), it was possible to desorb 100% of the oxygen (reducing the EPO conversion rate to 0.0 mol%) by heating at 100°C for 4 hours, which confirmed that the oxygen adsorption was a reversible reaction.

[0100] As described above, since the MOF of the present disclosure can control the adsorption and desorption of oxygen by external forces such as light or heat, rather than by increasing or decreasing the oxygen pressure, it has been found that the MOF of the present disclosure can be used in oxygen enrichment devices, oxygen storage devices, oxygen removal devices, and oxygen generation devices.

Claims

1. An oxygen adsorbing material comprising a metal-organic framework, the metal organic framework comprises a metal ion, a first ligand, and a second ligand; The pore volume after the solvent removal treatment is 2.0 vol% or more, the metal ion is a zinc ion, The first ligand is an organic compound that has no charge and has an anthracene structure; and The second ligand is an organic compound ion having two or more coordinating groups and having a negative charge. Oxygen adsorbing material.

2. The oxygen adsorbing material according to claim 1 , wherein the first ligand comprises a pyridyl group as a functional group that coordinates with the metal ion.

3. The oxygen adsorbing material of claim 2, wherein the first ligand comprises 9,10-di(4-pyridyl)anthracene or 9-(4-pyridyl)anthracene.

4. The oxygen adsorbing material according to any one of claims 1 to 3, wherein the second ligand comprises a polyvalent carboxylate ion.

5. 5. The oxygen adsorbing material of claim 4, wherein the second ligand comprises a 2,6-naphthalenedicarboxylate ion, a 4,4'-biphenyldicarboxylate ion, or a 4,4',4'',4'''-benzene-1,2,4,5-tetrayltetrabenzoate ion.

6. An oxygen enrichment device, an oxygen storage device, an oxygen removal device, or an oxygen generation device, comprising the oxygen adsorption material described in any one of claims 1 to 5.

Citation Information

Patent Citations

  • Solid electrolytic capacitor

    US20050105250A1